An international, randomized, placebo-controlled, Phase 3 clinical trial of the investigational drug STR001 in patients following a Sudden Sensorineural Hearing Loss (SSNHL) event.
Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as it points to a further drop in applicant numbers and vacancies.